Lusutrombopag
Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.
Product Specifications
CAS Number
1110766-97-6
Product Name Alternative
S-888711
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Thrombopoietin Receptor
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Lusutrombopag.html
Purity
98.88
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(O)/C(C)=C/C1=C(Cl)C=C(C(NC2=NC(C3=CC=CC([C@@H](OCCCCCC)C)=C3OC)=CS2)=O)C=C1Cl
Molecular Formula
C29H32Cl2N2O5S
Molecular Weight
591.55
Precautions
H302, H315, H319, H335
References & Citations
[1]Kim ES, et al. Lusutrombopag: First Global Approval. Drugs. 2016 Jan;76 (1) :155-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040266-100 1x 100 µL
Human IgG Immunoglobulin (IG266), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470266-100 1x 100 µL
Human IgG Immunoglobulin (IG266), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940158-100 1x 100 µL
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881888-500 1x 500 µL
CD1a / HTA1 (Mature Langerhans Cells Marker) (rC1A/711), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 